Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	842.4	941.48	1,105	1,274	1,506	193.46
Trading Asset Securities	180.19	100.01	75.52	0.12	3.97	-
Cash & Short-Term Investments	1,023	1,041	1,181	1,274	1,510	193.46
Cash Growth	-13.91%	-11.80%	-7.33%	-15.61%	680.49%	43.70%
Accounts Receivable	289.84	261.14	227.37	237.35	177.37	124.68
Other Receivables	23.55	15.17	15.39	10.66	16.79	9.89
Receivables	313.39	276.32	242.76	248.01	194.16	134.57
Inventory	934.66	962.01	760.22	699.43	521.86	476.55
Prepaid Expenses	-	3.64	4.19	5.61	2.47	0.04
Other Current Assets	28.65	21.38	20.7	33.92	16.19	13.1
Total Current Assets	2,299	2,305	2,209	2,261	2,245	817.71
Property, Plant & Equipment	135.32	153.02	166.88	97.32	75.45	60.04
Goodwill	7.56	7.56	-	-	-	-
Other Intangible Assets	4.59	4.93	3.95	0.6	0.21	0.44
Long-Term Deferred Tax Assets	26.59	23.91	14.74	18.36	3.88	2.97
Long-Term Deferred Charges	15.4	19.7	23.74	37.58	16.81	22.13
Other Long-Term Assets	0.8	2.86	-	-	18.25	2.84
Total Assets	2,490	2,517	2,418	2,415	2,359	906.13

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	158	202.46	216.32	179.57	167.37	206.07
Accrued Expenses	23.31	44.35	31.38	36.26	30.1	18.57
Short-Term Debt	5.04	0.34	30.18	0.23	9.61	0.07
Current Portion of Long-Term Debt	19.09	4.55	-	-	-	-
Current Portion of Leases	-	14.6	14.06	15.88	-	-
Current Income Taxes Payable	44.18	19.22	12.85	6.49	6.22	8.39
Current Unearned Revenue	52.82	48.31	36.69	29.07	20.52	14.68
Other Current Liabilities	5.7	7.99	4.28	7.47	15.25	1.78
Total Current Liabilities	308.15	341.82	345.76	274.97	249.07	249.56
Long-Term Debt	81	83.25	-	-	-	-
Long-Term Leases	31.78	38.33	37.95	41.19	31.21	27.71
Long-Term Deferred Tax Liabilities	6.72	7.94	7.2	8.06	2.77	-
Other Long-Term Liabilities	0.07	0.07	-	1.27	-	-
Total Liabilities	427.72	471.4	390.91	325.49	283.05	277.27

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	90.88	90.88	90.88	90.88	64.92	48.69
Additional Paid-In Capital	1,801	1,793	1,755	1,754	1,776	483.24
Retained Earnings	366.88	363.51	289.63	252.08	242.48	96.51
Treasury Stock	-199.98	-199.98	-99.99	-	-	-
Comprehensive Income & Other	2.78	-1.63	-8.6	-6.96	-7.25	0.43
Shareholders' Equity	2,062	2,045	2,027	2,090	2,076	628.86
Total Liabilities & Equity	2,490	2,517	2,418	2,415	2,359	906.13

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	136.91	141.07	82.2	57.3	40.82	27.78
Net Cash (Debt)	885.69	900.41	1,099	1,217	1,469	165.68
Net Cash Growth	-5.75%	-18.04%	-9.72%	-17.17%	786.71%	40.92%
Net Cash Per Share	10.13	10.27	12.35	13.44	19.93	2.47
Filing Date Shares Outstanding	85.45	86.15	88.33	90.88	90.88	68.16
Total Common Shares Outstanding	85.45	86.15	88.33	90.88	90.88	68.16
Working Capital	1,991	1,963	1,863	1,986	1,996	568.15
Book Value Per Share	24.13	23.74	22.95	22.99	22.84	9.23
Tangible Book Value	2,050	2,033	2,023	2,089	2,076	628.42
Tangible Book Value Per Share	23.99	23.60	22.91	22.98	22.84	9.22
Buildings	-	76.58	85.07	16.58	16.58	16.58
Machinery	-	66.68	45.93	47.23	35.62	21.9
Construction In Progress	-	-	15.41	-	5.1	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error